Taken together, our findings highlighted the pathogenic mechanism of RUNX2-MMP1 axis in breast cancer, which further provided new insights into metastasis and chemoresistance of triple negative breast cancer. This evidence concerns the gene RUNX2 and triple-negative breast carcinoma.